(Q34741986)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Hypothalamic obesity in humans: what do we know and what can be done? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

J Pinkney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Williams

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

I MacFarlane

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

27-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

The descriptive epidemiology of craniopharyngioma.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Craniopharyngioma: endocrine sequelae of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Growth and endocrine sequelae of craniopharyngioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Long-term results of treatment for craniopharyngioma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Growth in children with craniopharyngioma following surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

An autonomic hypothesis for hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

The role of vagally-medicated hyperinsulinemia in hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Role of the preoptic-anterior hypothalamus in thermoregulation and fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Transient cataplexy after removal of a craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hypothermia due to hypothalamic involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hypothermia due to transient hypothalamic dysfunction in tuberculous meningitis with hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hypothalamic astrocytoma, hypothermia, and pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Late onset post-traumatic hypothalamic hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Effects of growth hormone treatment in children with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Towards a molecular understanding of Prader-Willi and Angelman syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Behavioral treatment of obesity in patients with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Treatment of covert food stealing in an individual with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Reduction of food theft and long-term maintenance of weight loss in a Prader-Willi adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Biliopancreatic Diversion in Prader-Willi Syndrome Associated with Obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Metabolic changes following gastroplasty in Prader-Willi syndrome--a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

The use of fluoxetine in an adolescent with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Effects of growth hormone on body composition and bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

A frameshift mutation in MC4R associated with dominantly inherited human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00052.X

10.1046/J.1467-789X.2002.00052.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12119657%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference